Understanding how drugs activate ion channels in the brain.
Mechanisms of stepwise activation and drug-modulation in ligand-gated ion channels.
This study is looking at how certain brain channels work when they interact with different substances, including medications like benzodiazepines, to better understand how they help with feelings of anxiety and sensory experiences.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-10866533 on NIH RePORTER |
What this research studies
This research investigates how ion channels in the brain are activated by different ligands and how drugs, particularly benzodiazepines, can modulate this process. Using advanced single-molecule fluorescence techniques, the study aims to track the binding events at these channels to understand the sequence of actions that lead to their activation. By focusing on cyclic nucleotide gated channels and GABAA receptors, the research seeks to uncover the energy dynamics involved in these critical cellular processes, which are essential for sensory perception and anxiety regulation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing anxiety disorders or those who may benefit from benzodiazepine treatments.
Not a fit: Patients with conditions unrelated to ion channel dysfunction or those not affected by benzodiazepine treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for anxiety and other conditions by enhancing our understanding of how benzodiazepines work at the molecular level.
How similar studies have performed: Previous research has shown promise in understanding ion channel mechanisms, but this approach using single-molecule tracking is relatively novel.
Where this research is happening
Austin, United States
- University of Texas at Austin — Austin, United States (Active)
Researchers
- Principal investigator: Goldschen-Ohm, Marcel Paz — University of Texas at Austin
- Study coordinator: Goldschen-Ohm, Marcel Paz
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.